GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Days Sales Outstanding

ANTCF (Aion Therapeutic) Days Sales Outstanding : 19.66 (As of Oct. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aion Therapeutic Days Sales Outstanding?

Aion Therapeutic's average Accounts Receivable for the three months ended in Oct. 2024 was $0.05 Mil. Aion Therapeutic's Revenue for the three months ended in Oct. 2024 was $0.25 Mil. Hence, Aion Therapeutic's Days Sales Outstanding for the three months ended in Oct. 2024 was 19.66.

The historical rank and industry rank for Aion Therapeutic's Days Sales Outstanding or its related term are showing as below:

ANTCF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.97   Med: 4.97   Max: 16.98
Current: 16.98

During the past 8 years, Aion Therapeutic's highest Days Sales Outstanding was 16.98. The lowest was 4.97. And the median was 4.97.

ANTCF's Days Sales Outstanding is ranked better than
94.92% of 965 companies
in the Drug Manufacturers industry
Industry Median: 72.04 vs ANTCF: 16.98

Aion Therapeutic's Days Sales Outstanding increased from Oct. 2023 (0.00) to Oct. 2024 (19.66).

Aion Therapeutic Days Sales Outstanding Historical Data

The historical data trend for Aion Therapeutic's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Days Sales Outstanding Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Days Sales Outstanding
Get a 7-Day Free Trial - - - - 5.45

Aion Therapeutic Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 24.33 20.66 4.75 19.66

Competitive Comparison of Aion Therapeutic's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aion Therapeutic's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Aion Therapeutic's Days Sales Outstanding falls into.


;
;

Aion Therapeutic Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Aion Therapeutic's Days Sales Outstanding for the fiscal year that ended in Apr. 2024 is calculated as

Days Sales Outstanding (A: Apr. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Apr. 2023 ) + Accounts Receivable (A: Apr. 2024 )) / count ) / Revenue (A: Apr. 2024 )*Days in Period
=( (0 + 0.004) / 1 ) / 0.268*365
=0.004 / 0.268*365
=5.45

Aion Therapeutic's Days Sales Outstanding for the quarter that ended in Oct. 2024 is calculated as:

Days Sales Outstanding (Q: Oct. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jul. 2024 ) + Accounts Receivable (A: Oct. 2024 )) / count ) / Revenue (A: Oct. 2024 )*Days in Period
=( (0.029 + 0.08) / 2 ) / 0.253*365 / 4
=0.0545 / 0.253*365 / 4
=19.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aion Therapeutic  (OTCPK:ANTCF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Aion Therapeutic Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Days Sales Outstanding
Comparable Companies
XCNQ:RIPP XCNQ:HERB XCNQ:CVGR TSXV:DHB XCNQ:AYUR XCNQ:BBM NEOE:TILT XCNQ:XBRA XCNQ:SE TSXV:MUSH ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
AION:Canada
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Website
https://www.aiontherapeutic.com
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.